South and Central America Radiotherapy Market

Market Introduction

Radiotherapy is majorly used to control the growth of the tumour and with the minimum exposure to the surrounding normal and healthy tissue. Radiotherapy uses high-energy radiation, generally x-rays, to destroy the cancer cells and treat tumours in the prostate, breast, head & neck, lung and at any other parts in the body where radiation treatment is indicated. Advances in radiotherapy have been made in the last few years, as improvements in imaging modalities, powerful computers and software and delivery systems have enabled technologies.

Thus, the rising prevalence of cancer across the region is expected to create a significant demand for radiotherapy in the coming years, which is further anticipated to drive the radiotherapy market.

The COVID? 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South and Central America. They have responded to the situation by closing borders, ordering quarantines, and imposing a host of restrictions to keep people confined at home. Additionally, Between May and June 2020, the Brazilian Radiotherapy Society (SBRT) created a questionnaire with 14 questions that was sent to all heads of Radiation Oncology departments across the country, which shows that during the pandemic, there was a significant drop in the number of radiotherapy patients in the country and that this effect was similar way among the services, regardless of their characteristics and coping measures adopted during the pandemic. The COVID-19 pandemic presented numerous impacts on health systems, social life, and human behavior worldwide. It remains a challenge for local communities. In Brazil, a decrease in the number of treated patients was observed in the radiotherapy department despite efforts to keep the treatment routine as normal as possible. Nevertheless, a higher decrease in the total number of sessions was detected, indicating a smaller number of fractions/patients overall. These factors had a potential impact on the South and Central America radiotherapy market.

Market Overview and Dynamics

The Radiotherapy market in South and Central America is expected to grow from US$ 486.4 million in 2021 to US$ 691.6 million by 2028; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028. In December 2019, Elekta signed a strategic collaboration with ViewRay, Inc. to enhance functionalities and applications of MR-guided radiation therapy. As a part of the collaboration, Elekta invested in ViewRay Inc. with an amount equivalent to 9.9% of ViewRay’s shares. The companies are also agreed to work upon reduced radiation exposure for better treatment outcomes. Focus on development of such technologies will eventually drive the adoption of radiotherapy in years to come, which will ultimately boost the market growth.

Key Market Segments

In terms of type, the external-beam radiation therapy segment accounted for the largest share of the South and Central America radiotherapy market in 2020. In terms of product, the external beam radiotherapy products segment accounted for the largest share of the South and Central America radiotherapy market in 2020. In terms of application, the breast cancer segment accounted for the largest share of the South and Central America radiotherapy market in 2020. In terms of end user, the hospitals segment held a larger market share of the radiotherapy market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the Radiotherapy market in South and Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries, Ltd., Hitachi, Ltd., Koninklijke Philips N.V., Brainlab AG, Elekta AB, and Varian Medical Systems, Inc.

Reasons to buy report

• To understand the South and Central America Radiotherapy market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for South and Central America Radiotherapy market
• Efficiently plan M&A and partnership deals in South and Central America Radiotherapy market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South and Central America Radiotherapy market
• Obtain market revenue forecast for market by various segments from 2021-2028 in South and Central America region.

SOUTH AND CENTRAL AMERICA RADIOTHERAPY MARKET SEGMENTATION

By Type

• External-Beam Radiation Therapy
• Internal Radiation Therapy
• Systemic Radiotherapy/Radiopharmaceuticals

By Product

• External Beam Radiotherapy Products
• Internal Radiotherapy Products
• Radiotherapy Software
• Others

By Application

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Cervical Cancer
• Liver Cancer
• Thyroid Cancer
• Lymphoma
• Spine Cancer
• Brain Cancer
• Others

By End User

• Hospitals
• Specialty Clinics
• Radiation Therapy Centres

By Country

• South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America

Companies Mentioned

1. Siemens Healthineers AG                
2. Accuray Incorporated       
3. Sumitomo Heavy Industries, Ltd.                  
4. Hitachi, Ltd.           
5. Koninklijke Philips N.V.     
6. Brainlab AG           
7. Varian Medical Systems, Inc.
8. Elekta AB

South and Central America Radiotherapy Market Strategic Insights

South and Central America Radiotherapy Market Segmentation Analysis

South and Central America Radiotherapy Market Report Highlights

South and Central America Radiotherapy Report Scope

South and Central America Radiotherapy Market Country and Regional Insights